Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
Ashni Acquires BioNexus
March 1, 2000
1 Min Read
Ashni Acquires BioNexus
SALT LAKE CITY--Ashni Nutraceuticals, developer and marketer of nutraceuticalproducts, has announced the acquisition of BioNexus Genomics, developer ofpatent-pending genomic/proteomic/signal transduction technology, which is usedto develop functional foods and proprietary dietary supplements. The acquisitionwill provide Ashni with access to technology to use in the development of itsbotanical and nutritional formulations.
"With the addition of genomic, proteomic and signal transductiontechnologies, Ashni will standardize quality and discover patentable combinationproducts with proven synergistic effect," said Ashni chairman, presidentand chief executive officer, Dinesh Patel.
You May Also Like